YARW Stock Analysis — YARROW BIOSCIENCE INC (Healthcare >> Biotechnology)
YARW FAQ
What is YARW's dividend yield?
YARROW BIOSCIENCE INC offers a dividend yield of 0.00%.
Is now a good time to buy YARW?
Our AI Timing Score for YARW is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does YARW belong to?
YARROW BIOSCIENCE INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange
YARW AI Analysis Summary
Our AI summary for YARW: YARROW BIOSCIENCE INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, a dividend yield of 0.00%. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 35.02
Price
2.03
(6.15%)
Day Change
|
|
|---|
Not enough data to analyze.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 35.02 |
| PBV / Sector |
20.59 / 5.20
|
| Earning Per Share | N/A |
| PE / Sector |
N/A / 19.97
|
| PEG or PE/Growth / Sector |
N/A / 1.22
|
| Average 1M Daily Value |
0.65 M
GREAT
|
| Average 1W Daily Value |
0.65 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
% |
| Ability to Make Profit |
|
% |
| Return to Investors |
|
% |
| Registration Details |
| Analyze Date | |
| Symbol | YARW |
| Name | YARROW BIOSCIENCE INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 0.00 |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 168.62 / 9,903.94 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 40 10 th Avenue, New York, NY, United States, 10014
Phone: -
Website: https://www.yarrowbioscience.com
Employees: -
Sector: Healthcare >> Biotechnology
Description: Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › BiotechnologyAnalysed on the same criteria, ordered by market cap
Google